M. Heyman et al., PROGNOSTIC IMPORTANCE OF P15(INK4B) AND PL6(INK4) GENE INACTIVATION IN CHILDHOOD ACUTE LYMPHOCYTIC-LEUKEMIA, Journal of clinical oncology, 14(5), 1996, pp. 1512-1520
Purpose: The present study explores the prognostic importance of p16(I
NK4)/P15(INK4B) gene inactivation in childhood acute lymphocytic: leuk
emia (ALL). Materials and Methods. Cells from 79 pediatric ALL patient
s were investigated for inactivation of the p15(INK4B) and p16(INK4) g
enes or loss of heterozygosity (LOH) for chromosome 9p markers by use
of Southern hybridization, restriction fragment length polymorphism (R
FLP) analysis, microsatellite analysis as well as single-strand confor
mation polymorphism (SSCP) analysis, and nucleotide sequencing of the
p15(INK4B) and p16(INK4) genes. Genetic data were correlated to clinic
al outcome and established prognostic factors. Results: Inactivation o
f the p15(INK4B) and/or p16(INK4) genes by homozygous deletion or loss
of one allele and mutation of the other wets detected in 24 cases (30
%), Another 12 patients (15%) showed loss of one allele. A statistical
ly significant correlation was found between inactivation of the p15(I
NK4B)/p16(INK4) genes and poor prognosis (P < .01), Furthermore, inact
ivation proved to be on independent factor that predicted relapse, ran
king second to WBC count, The trend toward overrepresentation of treat
ment failure was strongest in the high-risk (HR) group patients with p
16(INK4)/p15(INK4B) gene inactivation. Patients with deletion of genet
ic material on 9p21 and normal coding sequence of the remaining p16(IN
K4) and p15(INK4B) genes had a similar prognosis to that of nondeleted
cases. Conclusion: The data suggest that analysis of p15(INK4B)/p16(I
NK4) genes may contribute prognostic information in pediatric ALL. (C)
1996 by American Society of Clinical Oncology.